Email this article Extremely high concentration of mexotrexate in blood serum leading to development of acute renal failure in a patient with acute lymphoblastic leukemia after high-dose consolidation
- Authors: Pimenova M.A.1, Sokolov A.N.1, Biryukova L.S.1, Ustinova E.N.1, Shaforostova I.I.1, Donskova I.A.1, Bogdanov R.F.1, Parovichnikova E.N.1, Savchenko V.G.1, Pimenova MA2, Sokolov AN2, Biryukova LS2, Ustinova EN2, Shaforostova II2, Donskova IA2, Bogdanov RF2, Parovichnikova EN2, Savchenko VG2
-
Affiliations:
- Hematological Research Center, Moscow
- Issue: Vol 83, No 7 (2011)
- Pages: 58-61
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30890
- ID: 30890
Cite item
Full Text
Abstract
About the authors
Mariya Anatol'evna Pimenova
Email: maria_pimenova@mail.ru
Andrey Nikolaevich Sokolov
Email: cat@blood.ru
Lyudmila Semenovna Biryukova
Email: birjukova@blood.ru
Elena Nikolaevna Ustinova
Inna Ivanovna Shaforostova
Email: shiil@yandex.ru
Irina Anatol'evna Donskova
Email: irina.donskova99@mail.ru
Rashit Fargatovich Bogdanov
Email: rashit85@mail.ru
Elena Nikolaevna Parovichnikova
Email: elenap@blood.ru
Valeriy Grigor'evich Savchenko
Email: svg@blood.ru
M A Pimenova
Hematological Research Center, MoscowHematological Research Center, Moscow
A N Sokolov
Hematological Research Center, MoscowHematological Research Center, Moscow
L S Biryukova
Hematological Research Center, MoscowHematological Research Center, Moscow
E N Ustinova
Hematological Research Center, MoscowHematological Research Center, Moscow
I I Shaforostova
Hematological Research Center, MoscowHematological Research Center, Moscow
I A Donskova
Hematological Research Center, MoscowHematological Research Center, Moscow
R F Bogdanov
Hematological Research Center, MoscowHematological Research Center, Moscow
E N Parovichnikova
Hematological Research Center, MoscowHematological Research Center, Moscow
V G Savchenko
Hematological Research Center, MoscowHematological Research Center, Moscow
References
- LaCasce Ann S. MD Therapeutic use of high-dose methotrexate. http:// www.uptodate.com/patients/.
- Warrier A. R., Rejiv R., Biswajit D. et al. High-dose methotrexate in the treatment of acute lymphoblastic leukemia: Toxicity profile and comparison of tolerability betwen two dosage schedules. J. Clin. Oncol. 2010; 28 (suppl 15): abstr. 9573.
- Widemann B. C., Adamson P. S. et al. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006; 1(6): 694-703.
- Pitman S. W., Frei E. 3rd. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat. Rep. 1977; 61 (4): 695-701.
- Flombaum C. D., Meyers P. A. et al. High-dose leucovorin as sole therapy for Methotrexate toxicity. J. Clin. Oncol. 1999; 17(5): 1589.
- Wilmanns W., Sauer H., Schalhorn A. et al. Biochemical control of high-dose methotrexate/Leucovorin rescue therapy. Recent Results Cancer Res. 1980; 74: 42-49.
- Schmiegelow K. Advances in individual prediction of methotrexate toxicity: a review. Br. J. Haematol. 2009; 146(5): 489-503.
- Relling M. V., Fairclough D., Ayers D. et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J. Clin. Oncol. 1994; 12: 1667-1672.
- Schwartz S., Borner K., Müller K. et al. Glucarpidase (Carboxypeptidase G2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy. Oncologist 2007; 12(11): 1299-1308.
- Liu J. X., Chen J. P. Tan W., Lin D. X. Association between mothfr gene polymorphisms and toxicity of HDMTX chemotherapy in acute lymphocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16(3): 488-492.
- Chiusolo P., Reddiconto G., Casorelli I. et al. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann. Oncol. 2002; 13 (12): 1915-1918.
- Паровичникова Е. Н., Давидян Ю. Р., Исаев В. Г. Итоги лечения острых лимфобластных лейкозов взрослых по протоколу ОЛЛ-2005 как основа для новых исследований. Тер. арх. 2009; 7: 6-15.
- Fisher M. C., Cronstein B. N. Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J. Rheumatol. 2009; 36(3): 539-557.
Supplementary files
